Indoleamine 2,3-Dioxygenase (IDO) Activity during the Primary Immune Response to Influenza Infection Modifies the Memory T Cell Response to Influenza Challenge

Viral Immunology

Volumn 27, Issue 3, 2014, Pages 112-123

  Sage, Leo K ^a   Fox, Julie M ^a   Mellor, Andrew L ^b   Tompkins, Stephen M ^a   Tripp, Ralph A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANZYME B; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 4; 1-METHYLTRYPTOPHAN; ENZYME INHIBITOR; IMMUNOLOGIC FACTOR; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLUENZA; INFLUENZA A; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA VIRUS A; LUNG; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; TREATMENT OUTCOME; VIROLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME INHIBITORS; FEMALE; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLUENZA A VIRUS; LUNG; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 84919415464     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0105     Document Type: Article

References (57)

1. 2009 Hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009;58:536-541.
2. Baban B, Chandler PR, Sharma MD, et al. IDO activates regulatory cells and blocks their conversion into Th17-like T cells. J Immunol 2009;183:2475-2483.
3. Baumgarth N, and Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 1996;70:4411-4418.
4. Belladonna ML, Volpi C, Bianchi R, et al. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDOcompetent dendritic cells. J Immunol 2008;181:51945198.
5. Belz GT, Xie W, and Doherty PC. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8 + T cell responses. J Immunol 2001; 166:4627-4633.
6. Boasso A, Hardy AW, Anderson SA, et al. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One 2008; 3:e2961.
7. Bot A, Bot S, and Bona CA. Protective role of gamma interferon during the recall response to influenza virus. J Virol 1998;72:6637-6645.
8. Cecchinato V, Tryniszewska E, Ma ZM, et al. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 2008;180:5439-5447.
9. Chaperot L, Blum A, Manches O, et al. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 2006;176:248-255.
10. Chen W, Liang X, Peterson AJ, et al. The indoleamine 2,3- dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008;181:5396-5404.
11. Coquerelle C, Oldenhove G, Acolty V, et al. Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. Gut 2009;58:1363-1373.
12. Doherty PC, Hou S, and Tripp RA. CD8 + T-cell memory to viruses. Curr Opin Immunol 1994;6:545-552.
13. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002;9:1069-1077.
14. Fitzgerald P, Cassidy Eugene M, Clarke G, et al. Tryptophan catabolism in females with irritable bowel syndrome: Relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil 2008; 20:1291-1297.
15. Fox JM, Sage LK, Huang L, et al. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection. J Gen Virol 2013;94:1451-1461.
16. Gabbard J, Velappan N, Di Niro R, et al. A humanized anti- M2 scFv shows protective in vitro activity against influenza. Protein Eng Des Sel 2009;22:189-198.
17. Ge X, Tan V, Bollyky PL, et al. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010;84:3312-3319.
18. Graham MB, Braciale VL, and Braciale TJ. Influenza virusspecific CD4 + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994;180:1273-1282.
19. Gras S, Kedzierski L, Valkenburg SA, et al. Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 2010;107:12599-12604.
20. Gudmundsson G, and Hunninghake GW. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997;99:2386-2390.
21. Guillonneau C, Mintern JD, Hubert FX, et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci USA 2009;106:3330-3335.
22. Haeryfar SM, DiPaolo RJ, Tscharke DC, et al. Regulatory T cells suppress CD8 + T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol 2005;174:3344-3351.
23. Harty JT, and Badovinac VP. Shaping and reshaping CD8 + T-cell memory. Nat Rev Immunol 2008;8:107-119.
24. Hoppner M, Luhm J, Schlenke P, et al. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods 2002;267:157-163.
25. Hou DY, Muller AJ, Sharma MD, et al. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res 2007;67:792-801.
26. Hou S, and Doherty PC. Partitioning of responder CD8 + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J Immunol 1993;150:5494-5500.
27. Hou S, Hyland L, Ryan KW, et al. Virus-specific CD8 + Tcell memory determined by clonal burst size. Nature 1994; 369:652-654.
28. Hryniewicz A, Boasso A, Edghill-Smith Y, et al. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006;108:3834-3842.
29. Huengsberg M, Winer JB, Gompels M, et al. Serum kynurenine-to-tryptophan ratio increases with progressive disease inHIV-infected patients. Clin Chem 1998;44:858-862.
30. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003;31:S213-220.
31. Janssen EM, Lemmens EE, Wolfe T, et al. CD4 + T cells are required for secondary expansion and memory in CD8 + T lymphocytes. Nature 2003;421:852-856.
32. Jurgens B, Hainz U, Fuchs D, et al. Interferon-gammatriggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 2009;114:3235-3243.
33. Laich A, Neurauter G, Widner B, and Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002;48:579-581.
34. Li L, Xia Y, Nguyen A, et al. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J Immunol 1998;161: 3128-3135.
35. Mahanonda R, Sa-Ard-Iam N, Montreekachon P, et al. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol 2007;178:1151-1157.
36. Marshall DR, Turner SJ, Belz GT, et al. Measuring the diaspora for virus-specific CD8 + T cells. Proc Natl Acad Sci USA 2001;98:6313-6318.
37. Mellor AL, Baban B, Chandler PR, et al. Cutting edge: CpG oligonucleotides induce splenic CD19 + dendritic cells to acquire potent indoleamine 2,3-dioxygenasedependent T cell regulatory functions via IFN Type 1 signaling. J Immunol 2005;175:5601-5605.
38. Mullarky IK, Szaba FM, Winchel CG, et al. In situ assays demonstrate that interferon-gamma suppresses infectionstimulated hepatic fibrin deposition by promoting fibrinolysis. J Thromb Haemost 2006;4:1580-1587.
39. Munn DH, Sharma MD, Baban B, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005; 22:633-642.
40. Munn DH, Sharma MD, and Mellor AL. Ligation of B7-1/ B7-2 by human CD4 + T cells triggers indoleamine 2,3- dioxygenase activity in dendritic cells. J Immunol 2004; 172:4100-4110.
41. Narasaraju T, Yang E, Samy RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011; 179:199-210.
42. Onodera T, Jang MH, Guo Z, et al. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/ CCR4 interactions. J Immunol 2009;183:5608-5614.
43. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361: 680-689.
44. Ponchio L, Duma L, Oliviero B, et al. Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long-term culture assays. Cytotherapy 2000;2:281-286.
45. Robertson SJ, Messer RJ, Carmody AB, and Hasenkrug KJ. In vitro suppression of CD8 + T cell function by Friend virus-induced regulatory T cells. J Immunol 2006;176: 3342-3349.
46. Robinson CM, Hale PT, and Carlin JM. The role of IFNgamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. J Interferon Cytokine Res 2005;25:20-30.
47. Sharma MD, Baban B, Chandler P, et al. Plasmacytoid dendritic cells from mouse tumor-drainig lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 2007;117:2570-2582.
48. Sharma MD, Hou DY, Liu Y, et al. Indoleamine 2,3- dioxygenase controls conversion of Foxp3 + Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 2009;113:6102-6111.
49. Smith JH, Nagy T, Driskell E, et al. Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts. J Virol 2011;85:7572-7581.
50. Thompson WW, Shay DK, Weintraub E, et al. Influenzaassociated hospitalizations in the United States. JAMA 2004;292:1333-1340.
51. Tripp RA, Topham DJ, Watson SR, and Doherty PC. Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J Immunol 1997;158:3716-3720.
52. Tumpey TM, Garcia-Sastre A, Taubenberger JK, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005;79:14933-14944.
53. Turner SJ, Olivas E, Gutierrez A, et al. Disregulated influenza A virus-specific CD8+ T cell homeostasis in the absence of IFN-gamma signaling. J Immunol 2007;178:7616-7622.
54. Welsh RM, Che JW, Brehm MA, and Selin LK. Heterologous immunity between viruses. Immunol Rev 2010;235: 244-266.
55. Wiley JA, Cerwenka , Harkema JR, et al. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol 2001;158: 119-130.
56. Xu H, Oriss TB, Fei M, et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA 2008;105:6690-6695.
57. Yoshida R, Urade Y, Tokuda M, and Hayaishi O. Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA 1979;76:4084-4086.